Name | HBV-IN-39-d3 |
---|
Description | HBV-IN-39-d3 (Example 14) is a deuterated HBV-IN-39 (Example 13). HBV-IN-39 is an HBV inhibitor. HBV-IN-39-d3 has better oral bioavailability than HBV-IN-39[1]. |
---|---|
Related Catalog | |
References |
[1]. Yi Chen, et al. Therapeutic agents for the treatment of HBV infection. Patent CN110240596B. |
Molecular Formula | C23H25D3FNO6 |
---|---|
Molecular Weight | 436.49 |